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Many proteins contain a thioredoxin (Trx)-like domain fused
with one or more partner domains that diversify protein func-
tion by the modular construction of new molecules. The Esche-
richia coli protein YbbN is a Trx-like protein that contains a
C-terminal domain with low homology to tetratricopeptide
repeat motifs. YbbN has been proposed to act as a chaperone or
co-chaperone that aids in heat stress response andDNA synthe-
sis. We report the crystal structure of YbbN, which is an elon-
gated molecule with a mobile Trx domain and four atypical tet-
ratricopeptide repeat motifs. The Trx domain lacks a canonical
CXXC active site architecture and is not a functional oxi-
doreductase. A variety of proteins in E. coli interact with YbbN,
including multiple ribosomal protein subunits and a strong
interactionwithGroEL. YbbNacts as amild inhibitor ofGroESL
chaperonin function and ATPase activity, suggesting that it is a
negative regulator of the GroESL system. Combined with previ-
ous observations that YbbN enhances the DnaK-DnaJ-GrpE
chaperone system,wepropose thatYbbNcoordinately regulates
the activities of these two prokaryotic chaperones, thereby help-
ing to direct client protein traffic initially to DnaK. Therefore,
YbbN may play a role in integrating the activities of different
chaperone pathways in E. coli and related bacteria.
Thioredoxin (Trx)2 is a widely distributed and extensively
studied thiol-disulfide oxidoreductase that protects organisms
from the deleterious effects of reactive oxygen species through
the action of two conserved active site cysteine residues (1). In
addition, Trx also has a role in cell signaling that is important in
higher eukaryotes (2). Although the role of Trx in the oxidative
stress response is well established, a large number of proteins
from all kingdoms of life contain one ormore Trx-like domains
fused to various other domains. The diversity of the partner
domain(s) in Trx domain-containing proteins is remarkable,
with 300 different partners identified from all sequenced
genomes by the SUPERFAMILYwebserver (3). In combination
with the intrinsic functional plasticity of the Trx domain itself
(4, 5), these domain fusions generate remarkable functional
diversity in the Trx-like proteins. Despite the abundance of
proteins containing a Trx domain fused to another domain,
the functions and structures of many of these proteins are
unknown.
The conserved prokaryotic protein YbbN exemplifies one
such family of Trx-domain containing proteins. YbbN is a
31-kDaEscherichia coliproteinwith anN-terminal Trx domain
and a C-terminal domain with poor homology to known con-
served domains. YbbN gene expression is significantly induced
by heat shock (6) or upon overexpression of the heat shock
-factor 32 encoded by the rpoH gene (7). Physiologically,
ybbN-deficient E. coli have been reported to display an
increased sensitivity to heat stress (8) and show defects in DNA
synthesis and cell division (9). YbbN physically interacts with
multiple components of the DNA polymerase III holoenzyme
(9) and with the chaperones DnaK and GroEL (8), suggesting
that YbbN may promote the proper folding or assembly of key
proteins involved in DNA replication and stress response.
Therefore, defects in these processes have been proposed to
result in the phenotypes associated with YbbN deficiency.
Although YbbN has been implicated in facilitating proper
protein quality control and folding,many of the details of YbbN
biochemical activity remain unclear. YbbN was initially
reported to possess a weak thiol-disulfide protein oxidoreduc-
tase activity in an in vitroRNase A disulfide isomerization assay
(10). However, the conserved thioredoxin CXXC active site
motif necessary for this activity is mutated to a SXXC sequence
in E. coli YbbN. The reported oxidoreductase activity was pro-
posed to result from a non-canonical active site comprising the
conserved Cys-38 and a distal but more highly conserved
Cys-63 as a second redox active cysteine residue (10). However,
a subsequent report from the same group noted that the in vivo
relevance of this weak activity is uncertain, as a ybbN-deficient
strain of E. coli does not display increased sensitivity to oxida-
tive stress, and no clear evidence was found for YbbN oxi-
doreductase activity in vivo (8).
More recently, an alternative chaperone activity has been
proposed for YbbN. Caldas et al. (10) found that YbbN alone is
able to facilitate the refolding of urea-denatured citrate syn-
thase (CS), -glucosidase or -clamp DnaN in vitro with an
efficiency comparable to chaperones like DnaK and other heat
shock proteins. However, a contradictory result was briefly
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mentioned by Pan and Bardwell (5) using CS as a substrate.
Moreover, YbbN alone cannot suppress the heat-induced
aggregation of CS at 43 °C, which is an alternative in vitro chap-
erone assay (10). YbbN physically interacts with GroEL and
DnaK (8, 11) as well as other proteins in pulldown experiments,
and YbbN deletion strains show reduced levels of these two
chaperone proteins (8). Furthermore, YbbN can enhance the
rate of citrate synthase refolding by theDnaK-DnaJ-GrpE chap-
erone complex in vitro (8). Considered together, these results
suggest that YbbNmay bemore active as a co-chaperone for the
DnaK system than as a chaperone in isolation. Additionally,
YbbNmay be a specific chaperone for components of the DNA
polymerase holoenzyme, as recently suggested (9).
To clarify the structural basis of YbbN function, we have
determined the x-ray crystal structure of YbbN at 1.8 Å resolu-
tion. The structure shows that the protein consists of a loosely
tethered N-terminal Trx domain and a divergent C-terminal
tetratricopeptide repeat (TPR) motif fold that possesses
unusual structural features. The protein is negatively charged
over most of its solvent-exposed surface and is a highly prolate
monomer in solution. The Trx domain of YbbN does not have
an active site structure that is conducive to thiol-disulfide
exchange chemistry, supporting the conclusion that the weak
oxidoreductase activity of the protein is likely not physiologi-
cally relevant. Immobilized YbbN interacts with a variety of
proteins in pulldown assays, including a strong interactionwith
GroEL. Unexpectedly, the chaperone and ATPase activities of
the GroESL chaperonin complex are mildly inhibited by YbbN
in an in vitro refolding assay. In total, these results suggest a
hypothesis that YbbN proteins may play a role in coordinating
the activities of key bacterial chaperone systems.
EXPERIMENTAL PROCEDURES
YbbN, GroEL, and GroES Cloning, Expression, and Puri-
fication—The full-length coding sequences for YbbN, GroEL,
and GroES were PCR-amplified from E. coli genomic DNA
using primers that introduced NdeI (5) and XhoI (3) restric-
tion enzyme sites at the indicated ends of the amplified prod-
ucts. These coding sequences were cloned between the NdeI
and XhoI sites of the bacterial expression vector pET15b, and
the recombinant proteins were expressed in BL21(DE3) E. coli
grown in Luria-Bertani medium supplemented with 100g/ml
ampicillin at 37 °C with shaking. Once the A600 of the culture
reached 0.6–0.8, it was equilibrated at 20 °C for 1 h before
induction of protein expression by the addition of 0.2 mM iso-
propyl -D-1-thiogalactopyranoside. The induced culture was
incubated at 20 °C with shaking overnight and harvested by
centrifugation. Cell pellets were stored at80 °C until needed.
The three proteins were expressed with thrombin-cleavable
N-terminal His6 tags for purification by metal affinity chroma-
tography. For each, the cell pelletwas resuspended in extraction
buffer (50 mM HEPES, pH 7.5, 300 mM NaCl, 0–10 mM imida-
zole, 2 mM DTT) supplemented with 1 mg/ml lysozyme and
sonicated to complete lysis. Cleared lysate was loaded onto
Ni2 metal affinity His-Select resin (Sigma), washed with
imidazole-supplemented extraction buffer (5 mM imidazole for
YbbN, 10 mM for GroES, and 5 mM for GroEL), and the recom-
binant proteins were eluted using 250 mM imidazole in extrac-
tion buffer. The N-terminal hexahistidine tag was removed by
thrombin cleavage for 4–8 h at 22 °C followed by dialysis
against storage buffer (25mMHEPES, 100mMKCl, 2mMDTT)
at 4 °C overnight for YbbNandGroELor incubation at 22 °C for
48 h with thrombin followed by dialysis at 4 °C for GroES. The
proteins were passed sequentially over His-Select resin to
remove any protein that retained the tag and then benzami-
dine-Sepharose resin to remove thrombin. For YbbN and
GroEL, the proteins were then passed over S-Sepharose resin
equilibrated in storage buffer as a subtractive purification step
to remove impurities; the purified protein is present in the flow-
through. The purified proteins were concentrated using a cen-
trifugal concentrator (Millipore) with a 10-kDa cutoff. YbbN
was concentrated to 26 mg/ml as determined by absorbance at
280 nm using a calculated extinction coefficient at 280 nm of
23,000 M1 cm1. Concentrations of GroEL and GroES were
calculated using 280 values of 10,555 and 1,490 M1 cm1,
respectively. The purified proteins were stored in storage
buffer, snap-frozen in 50–100 l aliquots on liquid nitrogen,
and stored at80 °C.
Reductive Lysine Methylation of YbbN—Initial sparse matrix
crystallization trials using YbbN did not produce diffraction-
quality crystals, so the protein wasmodified by reductivemeth-
ylation of lysines as described in Rypniewski et al. (12). Briefly,
purified YbbN protein was dialyzed against PBS (10 mM
Na2HPO47H2O, 1.7 mM KH2PO4,137 mM NaCl, 2 mM KCl)
buffer, pH 7.4, for 4 h to dilute the DTT present in the protein
storage buffer and then was reductively methylated by adding
20 l/ml of 1 M DMAB solution and 40 l/ml of 1 M formalde-
hyde. The reactionwas incubated for 2 h at 4 °C followed by two
additional cycles of DMAB and formaldehyde addition and
incubation and a final addition of 10 l/ml of 1 M DMAB and
incubation at 4 °C for 12 h. Unreacted reagents were removed
by dialysis against storage buffer.MethylatedYbbNproteinwas
concentrated to 22 mg/ml using a centrifugal concentrator
(Millipore) and ran as a single band with an apparent size of
32 KDa on overloaded Biosafe (Bio-Rad) Coomassie-stained
SDS-PAGE. The methylated protein migrates in SDS-PAGE
with a slightly larger apparent size than the unmethylated pro-
tein, possibly due to altered interaction of methylated YbbN
with the anionic SDS detergent in the gel. This mobility shift
was used to semiquantitatively monitor the extent and homo-
geneity of protein methylation when compared with unmodi-
fied protein. Themethylated YbbN protein was snap-frozen on
liquid nitrogen and stored at 80 °C. The specific lysines that
were methylated by this procedure were determined by trypsin
digestion of the protein overnight followed by liquid chroma-
tography MS-MS of the resulting peptides at the University of
Nebraska Mass Spectrometry Core facility.
Crystallization and Data Collection—For all crystallization
experiments, methylated YbbN protein at 22 mg/ml in storage
buffer was crystallized using the sitting drop vapor diffusion
method with drops containing 2 l of protein and 2 l of res-
ervoir solution. Initial conditions were obtained from a com-
mercial sparse matrix screen (Hampton Research) and opti-
mized. Tabular crystals in space groupP21 grewwithin 2 days at
room temperature against a reservoir solution of 20% poly-
ethylene glycol 8000, 0.2 M Ca(CH3COO)2, 0.1 M MES, pH 6.0.
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All crystals were cryoprotected by serial transfer through
increasing concentrations of ethylene glycol in the reservoir
solution to a final concentration of 25% (v/v), harvested in
nylon loops, and cryocooled by immersion into liquid nitrogen.
Diffraction data were collected at the Advanced Photon
Source,GM/CA-CATbeamline 23 ID-D froma single crystal of
YbbN maintained at 100 K. The crystal was illuminated with
incident X-rays of 12.66 KeV (0.98 Å), and a MARmosaic 300
CCD detector was used to collect the data. The crystal was
exposed to x-rays for 2 s per 1 degree of oscillation for a total of
360 degrees, and the resulting diffraction data were integrated
and scaled using HKL2000 (13). Final data statistics for each
data set are provided in Table 1.
Structure Determination, Refinement, and Validation—The
structure of YbbN was determined using maximum likelihood
molecular replacement as implemented in PHASER (14), part
of the CCP4 suite of programs (15). The searchmodel used was
based on 2R5S, a protein of unknown function from Vibrio
parahaemolyticuswhose structure determined by theMidwest
Center for Structural Genomics. Although 2R5Swas the closest
sequence homologue of known structure to YbbN in a BLAST
search (46% sequence identity), the aligned region is limited to
the C-terminal TPR domains (residues 111–284) of YbbN.
Despite high sequence identity, molecular replacement at-
tempts using the entire 2R5S model, a homology model built
using 2R5S, as well as various thioredoxin structures as search
models were all unsuccessful. Successful molecular replace-
ment solutions could only be obtained by using two truncated
versions (residues 115–193 and 194–284) of the YbbN homol-
ogy model built using 2R5S in Swissmodel (16) for sequential
molecular replacement searches. The initial model was
improved by automated model building in ARP/wARP (17) as
implemented in CCP4, which produced an excellent model for
residues 115–284 of YbbN. The quality of the electron density
in the N-terminal thioredoxin domain of YbbN, however,
remained poor due to disorder and required manual model
building in COOT (18).
The model was refined against an amplitude-based maxi-
mum likelihood target function using Refmac5 (19) in the
CCP4 suite. The model was refined against all measured data
with no intensity or amplitude cutoff, and a bulk solvent cor-
rection was used to allow the inclusion of low resolution reflec-
tions. Manual adjustments to the model, including construc-
tion of the solvent model, were performed in COOT. Dimethyl
lysine modifications resulting from the reductive methylation
protocol were introduced into the model at sites where the
electron density clearly supported the inclusion or where
trypsinization/mass spectrometry indicated a modified lysine.
The restraint files for dimethyl lysine used in refinement were
generated using the PRODRG webserver (20). Upon conver-
gence of the Refmac5 refinement with isotropic atomic dis-
placement parameters, the translation-libration-screw (TLS)
model was refined with three TLS rigid body groups (residues
6–31, 32–99, and 100–284) determined using TLSMD (21).
The application of TLS reduced Rfree (22) by 2.5%. The final
model was validated using MolProbity (23) and the validation
tools in COOT (18). Asp-180 is the only marginal residue in a
Ramachandran plot and acts as a bidentate ligand to a bound
calcium ion. This residue is well ordered and in unambiguous
electron density. All structural figures were made using
POVScript (24).
Sedimentation Equilibrium Ultracentrifugation—The solu-
tionmolecularmass of YbbNwas determined by sedimentation
equilibrium ultracentrifugation using a Beckman Coulter XL-I
analytical ultracentrifuge as previously described (25). YbbN
samples were prepared at 0.25, 0.50, and 1.0 mg/ml in 25 mM
HEPES, pH 7.5, 100 mM KCl, and 1 mM DTT, and the experi-
ment was conducted at 20 °C. The partial specific volume of
YbbN was calculated as 0.7405 ml g1 based on amino acid
sequence using SedNTerp (26). All nine datasets (three concen-
trations of protein at three rotor speeds) were combined and
globally fit to obtain molecular mass using Origin 6.
Identification of Proteins Interacting with YbbN—YbbN
affinity resin was made by covalently binding 40mg of purified,
unmodified YbbN protein in binding buffer (50mMHEPES, pH
7.5, 100 mM NaCl) onto 2 ml of cyanogen bromide-activated-
Sepharose 4 Fast Flow (Sigma) resin following the manufactur-
er’s instructions. For the binding experiments, a 4-g pellet of
packed E. coli K-12 strain MG1655 cells was resuspended in 50
mMHEPES, pH7.5, 100mMNaCl, 2mMDTTcontaining 200l
of protease inhibitor mixture P8849 (Sigma) and lysed by son-
ication. The lysate was clarified by centrifugation at 10,000 rpm
for 30 min at 4 °C, and the supernatant was collected and incu-
bated with the YbbN affinity resin overnight at 4 °C. The resin
was extensively washed with the binding buffer, and the pro-
teins specifically interacting with YbbN were eluted from the
column using binding buffer supplemented with 600 mM NaCl
followed by a second elution of tightly bound proteins using
TABLE 1
Data collection and refinement statistics
Data collection
X-ray source APS GM/CA 23ID-D
X-ray wavelength (Å) 0.98
Space group P21
Cell dimensions
a, b, c (Å) 29.52, 62.45, 79.98
 (degree) 96.57
Molecules in asymmetric unit 1
Wilson B factor (Å2) 23
Resolution (Å)a 100-1.8
Rmergeb 0.05 (0.37)
I/(I) 11.4 (2.3)
Completeness (%) 95.0 (79.2)
Redundancy 3.6 (2.5)
Refinement
PDB code 3QOU
Program REFMAC5
Resolution (Å) 79-1.8
No. reflections 25553
Rworkc; Rfreed; Ralle (%) 18.7; 23.9; 18.9
r.m.s.d.
Bond lengths (Å) 0.009
Bond angles (deg.) 1.01
Ramachandran plot: favored; allowed;
forbidden (%)
96; 100; 0
a Values in parentheses are for highest resolution shell.
bRmerge 	hkl	iIhkli  Ihkl/	hkl	iIhkli , where i is the ith observation of a
reflection with indices h,k,l, and angle brackets indicate the average over all i
observations.
c Rwork 	hklFhklo  Fhklc /	hklFhklo , where Fhklc is the calculated structure factor
amplitude with index h,k,l, and Fhklo is the observed structure factor amplitude
with index h,k,l.
d Rfree is calculated as Rwork, where the Fhklo is taken from a test set comprising 5%
of the data that were excluded from the refinement.
e Rall is calculated as Rwork, where the Fhklo includes all measured data (including
the Rfree test set).
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binding buffer supplemented with 1 M NaCl. The two elutions
were handled separately, and the retained proteins were con-
centrated by precipitation using a 10% trichloroacetic acid
(TCA), 80% cold acetone mixture that was incubated on ice for
2 h. Precipitated proteins were recovered by centrifugation,
washedwith cold 20%TCA inwater to remove any precipitated
salts, resuspended in SDS-PAGE running buffer, neutralized
with 5 N NaOH, and analyzed using SDS-PAGE. The individual
bands were excised from the gel and identified by in-gel trypsin
digestion followed by LC-MS/MS at theUniversity of Nebraska
Mass Spectrometry Core facility. To determine proteins avidly
bound to the YbbN resin, a sample of the resin was taken after
the 1.0 M NaCl elution, placed in SDS-PAGE loading buffer,
heated to 95 °C for 5 min, and the liberated proteins were ana-
lyzed by SDS-PAGE.
Chaperone-assisted Refolding of Citrate Synthase—Pig heart
citrate synthase (E.C. 2.3.3.1, Sigma) was completely denatured
at amonomer concentration of 20M in 6 M guanidine-HCl, 50
mM HEPES, pH 7.5, 20 mM dithiothreitol at 22 °C for 60 min.
Refolding was initiated by a 100-fold dilution of CS into refold-
ing buffer (100 mM HEPES, pH 7.5, 10 mM KCl, 10 mM MgCl2,
and 2mMATP) followed by incubation at 22 °C for 100min. For
the chaperone assays, GroEL (2 M), GroES (4 M), YbbN (4
M), or lysozyme (4 M) was present in the refolding buffer at
the indicated concentrations. Upon dilution, the substrate CS
was present at 0.2M, resulting in a 10–20-fold excess of chap-
erone to substrate. The enzymatic activity of refolded citrate
synthase was measured by adding 950 l of reaction solution
containing 100 mM HEPES, pH 7.5 buffer, 0.047 mM acetyl
coenzymeA (Sigma), 0.23mM oxaloacetic acid (Sigma), and 0.1
mM 5,5-dithiobis-(2-nitrobenzoic acid) (Invitrogen) to 50l of
the CS refolding mixture. After mixing with reaction solution,
CS activity was measured continuously using the absorption of
liberated 5-thio-2-nitrobenzoic acid at 412 nm for 90 s using a
Varian Cary50 spectrophotometer. The rate of reaction, which
is directly proportional to the amount of correctly folded CS,
was determined bymeasuring the slope of the linear increase in
412-nm absorption between 18 and 90 s. Native CS, treated in
the same way as the refolded sample but without denaturation,
was used as positive control and lysozyme (E.C. 3.2.1.17, Fisher)
was used as negative control. All measurements were repeated
at least three times with means and S.D. shown in Fig. 7. Stu-
dent’s t test was used to calculate the probability of the null
hypothesis using Microsoft Excel.
GroEL ATPase Activity Assay—The GroESL ATPase activity
assays were performed using the Malachite green phosphate
assay kit (BioAssay Systems). GroESL (1 M) or YbbN (2 M)
were added into the buffer containing 50 mM Tris-HCl, pH 8.0,
10 mM MgCl2, 10 mM KCl, 0.2 mM ATP, and incubated for 10
min at 22 °C. The enzyme reactions were terminated by the
addition of working agent from the kit. The absorbance at 620
nm was measured after 30 min of color development at 22 °C.
Bovine serum albumin (Invitrogen) was used at 2 M as nega-
tive control. All measurements were repeated at least three
times with means and S.D. shown in Fig. 7. Student’s t test was
used to calculate the probability of the null hypothesis using
Microsoft Excel.
RESULTS
Description of the Structure—YbbN is a two-domain protein
comprising an N-terminal Trx domain (residues 1–111) and a
set of four TPR motifs (residues 112–284) with an intervening
extended two helix region (180–212) that composes the C-ter-
minal domain. Themolecular surface of YbbN is defined by the
pendant Trx domain and the curved, saddle-shapedC-terminal
TPR domain (Fig. 1). The Trx domain is loosely tethered to the
TPR domain, and weak electron density in this region provides
clear evidence that the Trx domain ismobile in the crystal. This
mobility wasmodeled using theTLSmodel (27)with three rigid
domains (residues 6–31, 32–99, and 100–284) as determined
using the TLSMD webserver (21). The anisotropic atomic dis-
placement parameters calculated from the refined TLS model
show dramatically higher and more anisotropic mobility of the
Trx domain compared with the C-terminal TPR domain (Fig.
1E). This is supported by the much larger average B-factors for
atoms in the Trx domain (87 Å2) compared with those in the
remainder of the protein (24 Å2). The Trx domain bridges crys-
tal contacts between neighboring molecules in the crystal but
makes no direct packing contacts with the C-terminal domain,
suggesting that Trx domain mobility is likely to be more pro-
nounced in solution.
YbbN is an acidic protein (predicted pI 4.5), and the electro-
static surface potential calculated by APBS (28, 29) indicates
that both domains of the protein present a predominantly neg-
atively charged surface to solution (Fig. 1, C and D). However,
there are twopatches of neutral and basic residues inYbbN; one
located in the N-terminal Trx domain and the other in the two
C-terminal -helices comprising residues 255–284 (Fig. 1, C
andD). TheC-terminal cluster is themore basic of the two. The
molecule is also highly prolate,measuring90Å along the long
axis and 25 Å along the two shorter axes, which would be
expected to result in unusual hydrodynamic behavior. This is
relevant because a previously reported gel filtration experiment
indicated that reduced YbbN was dimeric, with an estimated
mass of 65 kDa (10). However, an analysis of lattice contacts in
the crystal structure shows no evidence of a significant dimeric
interface between neighboring molecules. The solution behav-
ior of YbbN was investigated using sedimentation equilibrium
centrifugation, which is insensitive to the shape of themolecule
and indicates that the reduced protein ismonomeric in solution
over the 8–30 M concentration range. An adequate fit to the
data can be obtained assuming a single idealmonomeric species
of 31.6 kDa, which is in excellent agreement with the calculated
monomeric mass of 32.1 kDa (Fig. 2). Inclusion of a more com-
plex self-association model does not improve the fit as judged
by the residuals or the reduced 2 value. Therefore, we propose
that YbbN is amonomer in solutionwhose prolate shape results
in an anomalous hydrodynamic volume that may have con-
founded previous mass estimates using gel filtration.
The Trx Domain Contains a Redox-inert Active Site—Se-
quence alignment has shown that the Trx domain of YbbN
contains only one of the two catalytic cysteine residues in the
Trx active site. In E. coli Trx, Cys-32 and Cys-35 define the
active site and participate in thiol-disulfide redox chemistry,
with the more reactive Cys-32 having a pKa value of 7,
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whereas Cys-35 has a pKa value of 10 (30). The lower pKa
value for Cys-32 is catalytically important, as it promotes
thiolate formation at physiological pH and initiates attack at
disulfide bonds in substrates (30). In YbbN, Cys-38 corre-
sponds to the high pKa Cys-35 in E. coli Trx, whereas YbbN
has redox-inactive Ser-35 in the location equivalent to the
more reactive Cys-32 in E. coli Trx, as previously noted
based on a homology model of the YbbN Trx domain (10).
YbbN possesses a second cysteine at residue 63 that has been
proposed to serve as an atypical second member of the two-
Cys active site (10) and is well conserved in YbbN-like pro-
teins. This residue is 7.5 Å away from Cys-38 (Fig. 3), which
is large compared with the 3.8 Å distance between thiols in
reduced E. coli thioredoxin (31). Therefore, disulfide forma-
tion between Cys-38 and Cys-63 would require significant
conformational changes in the Trx domain that would have
to bring these two thiols together across an intervening
-strand, which seems unlikely. Due to the absence of a
canonical Trx-like active site containing two cysteines and
relatively poor sequence conservation in this region, YbbN is
mostly likely not a thiol-disulfide oxidoreductase in vivo,
consistent with recent biochemical data (8). We note that
although the absence of a two-Cys motif in the YbbN Trx
domain makes a classical thiol-disulfide oxidoreductase
FIGURE 2.YbbN is amonomer in solution. Sedimentation equilibriumultra-
centrifugation of YbbNwas performed at three rotor speeds andprotein con-
centrations and globally fit to determine molecular mass. A representative
run is shown. The best-fit model (shown in the solid line in the lower panel)
corresponds to the YbbN monomer and agrees well with the measured
absorbance of the protein at 280 nm as a function of radius (open circles). The
residuals (top panel) between data and model are randomly distributed and
lack a systematic trend, indicating adequate fit.
FIGURE 1. Structure, electrostatics, and disorder in YbbN. In panel A, YbbN is shown as a ribbon diagram, with the N and C termini labeled. The Trx
domain is in gold, and the two TPR-containing subdomains are in blue (subdomain A) and purple (subdomain B). Helices are lettered and strands are
numbered in both panels A and B. The protein is highly prolate, and the Trx domain makes no direct contacts with the TPR domain. In panel B the ribbon
diagram of YbbN is shown rotated by 90 degrees about the horizontal. The electrostatic surface for YbbN is shown in panels C and D in the same
orientations as in panels A and B, with red representing negative electrostatic potential and blue representing positive. YbbN presents a predominantly
negatively charged surface to solution, particularly in the cleft between the two TPR subdomains. However, there is a basic (positive) patch of residues
near the C-terminal region of YbbN. Units of electrostatic potential are kT/e, and the temperature was 300 K. In panel E thermal ellipsoids at 75%
probability level for all C atoms are shown for the refined TLS model of domain mobility in YbbN, emphasizing the greatly elevated disorder of the Trx
domain compared with the better-ordered TPR domains. Ellipsoid color indicates the displacement magnitude, ranging from B values of 10 Å2 (blue) to
80 Å2 (red).
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activity unlikely, it does not completely exclude other poten-
tial redox-relevant activities.
YbbN Contains a Cryptic TPR Domain—The TPR domain of
YbbN contains two similar subdomains of five helices each that
are separated by a kink at residue 198. The structure of this
domain reveals that these subdomains each contain two tan-
dem TPRs; however, several sequence-based bioinformatics
tools failed to identify this region as containing TPR motifs
before structure determination. TPRpred (32) is the best-per-
forming of these programs and correctly predicted regions
114–148, 148–181, and 216–249 as TPRs with p values of
2 
 104 and a whole protein p value of 5 
 108, corre-
sponding to a 53% chance of YbbN being a TPR protein accord-
ing to the program. This prediction is accurate; however, the
YbbNTPRs diverge from the canonical TPRmotif and have, on
average, only 11% identity with a consensus TPR sequence (33).
Despite sharing only modest sequence similarity to other
TPR proteins, the peptide backbones of two C-terminal sub-
domains of YbbN individually superimpose well with the crys-
tal structure of a designed consensus TPR motif (33). Sub-
domain A of YbbN agrees better with the canonical TPR motif
(C r.m.s.d. of 1.4 Å from residues 112–198) than does sub-
domain B, which superimposes more poorly (C r.m.s.d. of 1.6
Å) and only over a more restricted core region (Fig. 4). In sub-
domain B, the best alignment was one in which YbbN sub-
domain B lacks the first helix of the first consensus TPR motif
and where there is one “extra” capping helix at the C terminus
(Fig. 4, B and D). This was a surprising result that violates the
standard topology ofTPRmotifs (34) butwas the optimal struc-
tural alignment using brute force least squares alignment opti-
mization in LSQMAN (35). We note that it is possible to align
subdomain B and the idealized TPR crystal structure in a way
that preserves the standard TPR topology and places all helices
FIGURE 3. The Trx domain of YbbN lacks a conventional CXXC active site.
A superposition of the Trx domain of YbbN (blue) and oxidized E. coli Trx (PDB
2TRX (49); yellow) is shown with the key cysteine residues of both proteins
shown in stick representation. Residue number corresponds to YbbN, and the
N and C termini of the domains are indicated. YbbN lacks the classical CXXC
motif because residue 35,which is themore reactive cysteine in Trx, is a serine
in YbbN. Although another cysteine residue (Cys-63) is present in YbbN, it is
too distant from Cys-38 to participate in Trx-like thiol-disulfide exchange
chemistry. This position is occupied by an isoleucine in Trx.
FIGURE 4. The C-terminal domain of YbbN contains atypical TPR motifs. The YbbN TPR motifs (blue) are superimposed with the crystal structure of an
idealized TPRmotif (PDB code1NA3; yellow). Inpanels A andB, the helices are represented as cylinders and are labeledAorB to indicate the correspondinghelix
of the idealized TPRmotif. N and C termini of the domains are labeled. Panel A shows the close agreement between TPR subdomain A of YbbN (blue) and the
idealized TPR motif (yellow). The capping helices are located on the C terminus of the domains. In panel B, the best superposition of YbbN TPR subdomain B
(blue) and the idealized TPRmotif (yellow) involves an unusual staggered alignmentwhere the YbbNTPR subdomain B lacks theN-terminal A helix andhas two
C-terminal capping helices. Panels C andD provide amore detailed view of the superimposed TPR domains in the same orientations as panels A and B. Highly
conserved TPR consensus residues that differ between YbbN and the idealized TPR motif are shown in stick representation, with standard TPR numbering as
described in Main et al. (33).
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into correspondence, but the quality of this alignment is mark-
edly poorer. Additionally, many core TPR “signature residues”
(33, 34) are substituted with other amino acids in YbbN, with a
notable preference for replacement of Tyr in the consensus
sequence with Leu (Fig. 4, C and D). Although the Leu and Tyr
are both hydrophobic residues, they differ significantly in side-
chain volume, and YbbN favors the smaller Leu at most con-
sensus Tyr positions in the TPR sequence.
TPR motifs often assemble into superhelical structures
whose large surface area provides a platform for protein inter-
action (34, 36). This type of superhelical TPR assembly in YbbN
would require oligomerization and is prevented by the capping
helices on the C terminus of TPR subdomain B and the Trx
domain at the protein N terminus. It is possible that these two
structural features on either end of the molecule function to
prevent multimerization of the protein and thereby help main-
tain soluble, monomeric YbbN. In addition, the C terminus of
the protein coordinates a calcium ion in this structure, and
residues in this region of YbbN are highly conserved (supple-
mental Figs. 1 and 2). The Ca2 binding site is composed of
residues from two molecules in the lattice and thus is likely an
artifact of the crystallization condition (which contains 200mM
Ca(CH3COO)2) and lattice packing. However, it is noteworthy
that the C-terminal regions of the related crystal structures
2R5S and 2QDN (see below) also interact with neighboring
molecules and buffer components and, furthermore, that this
region of YbbN is electrostatically distinct from the rest of the
protein (Fig. 1, C andD), hinting at a possible functional signif-
icance of the C-terminal region.
The two TPR motif subdomains in YbbN define a solvent-
filled groove that is rich in charged residues and may provide a
binding site for other proteins (Fig. 5). This cleft defines the
underside of the TPR domain “saddle” and is 26 Å long and
12–14 Å across the solvent-rich portion. A joint located at a
break between theC-terminal-helix in TPR subdomainA and
the N-terminal helix of subdomain B may allow for segmental
flexibility of the two TPR subdomains that could modulate the
cleft dimensions. The base of the cleft is rich in negatively
charged residues; however, several lysine and arginine residues
are present farther up on the cleft walls, creating a shallow and
electrostatically varied surface that is reminiscent of the inter-
action surface of the TPR-containing Hop protein with the
C-terminal peptide of Hsp90 (37). Several of these basic resi-
dues are well conserved in YbbN homologues (supplemental
Fig. 1), includingArg-231, Arg-244, Lys-245, Arg-274, Arg-276,
and Arg-277.
The TPR domain of YbbN is similar to a protein of unknown
function from Vibrio parahaemolyticus (PDB code 2R5S),
which was the most closely related protein of known structure
when the crystal structure of YbbN was being solved and was
used to determine the structure of YbbN by molecular replace-
ment. The reported 2R5S crystal structure is only the C-termi-
nal TPR domain of the full protein sequence, which includes an
N-terminal Trx domain and is a clear homologue of YbbN. In
addition, during the preparation of this manuscript, a crystal
structure for a YbbN homologue from Salmonella typhimu-
rium (PDB code 3QDN) was also deposited in the Protein Data
Bank. This protein and E. coliYbbN are 87% identical and share
all of the same structural features, although slight differences in
the relative orientations of the domains give rise to an overall
C r.m.s.d. of 2.5 Å despite having per-domain C r.m.s.d. val-
ues of0.6 Å.
YbbN Binds to GroEL—TPR motifs typically bind to other
proteins (34), suggesting that protein interaction may be an
important component of YbbN function. Supporting this con-
tention, prior studies have identified a variety of YbbN-inter-
acting proteins using the resin-immobilized protein as bait in
pulldown studies (8).We sought to determine whether the pre-
viously identified interactors could be corroborated in an inde-
pendent experiment. YbbNwas immobilized on cyanogen bro-
mide-derivatized resin and used to pull down interacting
soluble proteins from cleared E. coli K-12 lysate, similar to pre-
vious work (see “Experimental Procedures”). A number of
bound proteins could be eluted using 0.6 MNaCl (Fig. 6), whose
identities were determined by trypsinization/mass spectrome-
try and are shown in Table 2. Some of these proteins were pre-
viously identified in other interaction experiments, such as
GroEL and DnaK (8). One protein, DNA-directed RNA poly-
merase  (rpoB), is functionally related to previous identified
DNA polymerase III interactors (9). Several of the other inter-
acting proteins are ribosomal proteins as well as the E1 subunit
of pyruvate dehydrogenase and phosphoribosylpyrophosphate
synthetase. In contrast to previous reports (8), YbbN was not
identified as a self-interactor in this experiment, consistent
with structural results indicating a monomeric protein. In the
more stringent 1 M NaCl wash, highly purified GroEL is the
dominant protein visible on a Coomassie-stained SDS-PAGE
gel (Fig. 6), indicating avid and direct binding of these two pro-
teins. To identify very strongly associated proteins, a sample of
protein-bound resinwas heated in denaturing SDS-PAGE load-
ing buffer after the 1.0 M NaCl elution and analyzed by SDS-
PAGE. The gel shows two strong bands; one at57 kDa corre-
sponding to bound GroEL and one at32 kDa corresponding
to YbbN that had been removed from the resin by harsh dena-
turing elution (supplemental Fig. 3), supporting the conclusion
that GroEL binds robustly to YbbN.
FIGURE 5. A potential binding cleft in the TPR domain. The two TPR sub-
domains form a solvent-rich cleft in YbbN that may form an interaction sur-
face with other proteins. The YbbN peptide backbone is shown as a ribbon
diagram and is colored as in Fig. 1. A variety of charged amino acids are
located in this cleft, creating an electrostatically varied surface that may bind
to other proteins. Ordered water molecules are depicted as red spheres.
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YbbN Mildly Inhibits GroESL Chaperone and ATPase
Activities—Due to the apparently strong interaction between
YbbN and GroEL, the ability of YbbN to facilitate refolding of
CS either alone or in combination with the GroESL chaperonin
system was investigated. Guanidinium HCl-denatured CS was
diluted into refolding buffer containing the test protein and
allowed to refold for 100 min at room temperature followed by
a 5,5-dithiobis-(2-nitrobenzoic acid)-based activity assay to
determine the amount of recovered CS activity (see “Experi-
mental Procedures”). In contrast to a previous report (8), we
found that YbbN was no more effective than the negative con-
trol protein lysozyme at facilitating refolding of CS, indicating
that YbbN lacks foldase chaperone activity in this assay (Fig.
7A). We note, however, that this assay does not directly meas-
ure holdase chaperone activities, and thus it remains possible
that YbbN could possess such an activity that would not be
detected in this experiment. Additionally, although we do not
detect any chaperone activity for YbbN against the generic sub-
strate CS, a prior study indicates that YbbN may have a more
specific chaperone activity against substrates such as DnaN (9),
which we did not test. GroESL significantly enhanced the
recovery of CS enzymatic activity compared with the negative
control, as expected. Surprisingly, we found that YbbN mildly
inhibited GroESL chaperone activity when these proteins were
FIGURE 6. YbbN interacts with a variety of proteins in E. coli lysate. Pro-
teins retained fromsonicatedE. coli lysateonaYbbNaffinity resinwereeluted
with either a 0.6 M or a 1.0 M NaCl wash. Negative control lanes (C) were those
fractions that eluted from unmodified resin that had been incubated with
lysate. The gel was stained with Coomassie Blue, and numbers indicate pro-
tein bands that were excised and identified using mass spectrometry (see
Table 2 for identities). Band 4 is GroEL, which is the dominant protein present
in the more stringent 1 M NaCl wash and interacts robustly with YbbN.
TABLE 2
E. coli proteins that interact with YbbN
Protein band
number
Protein ID by
mass spectrometry
MASCOT protein
score
1 DNA-directed RNA polymerase  subunit 1754
2 Pyruvate dehydrogenase E1 1741
3a 30 S ribosomal protein S1; Hsp90, DnaK 2323; 1436; 1063
4 GroEL 9424
5 Elongation factor Tu 2039
6 Phosphoribosyl pyrophosphate synthetase 1920
7 30 S ribosomal subunit S2 700
8 50 S ribosomal subunit L1 753
9 50 S ribosomal subunit L6 1271
10b 30 S ribosomal subunit S2 544
11a 50 S ribosomal subunit L9; GroES 2131; 1144
12 50 S ribosomal subunit L24 1223
13 50 S ribosomal subunit L27 1017
a Protein bands for which there were multiple high confidence hits with compara-
ble protein molecular weights in mass spectrometric identification indicate that
a mixture of proteins was present in the band. These proteins are named and
separated by semicolons in the right-hand column.
b A high scoring hit that shows a disparity in the predicted protein mass and
observed band migration.
FIGURE 7. GroESL activity is mildly inhibited by YbbN. Panel A shows the
amount of CS activity recovered from chemically denatured enzyme thatwas
refolded by dilution into buffer containing the proteins indicated by a sign
in the table at the bottomof the graph. The reactionwas followedbymonitor-
ing the production of colored 2-nitro-5-thiobenzoate by liberated CoA.
Native CS, which had not been denatured before the assay, is the positive
control. The GroESL chaperonin leads to a substantial recovery of CS activity
that is diminished by the addition of YbbN. The asterisk indicates that the
difference between values with and without YbbN is significant to a p value
0.05 by Student’s t test for data generated from three independent exper-
iments. YbbN alone is no more effective than the negative control protein
lysozyme at refolding CS. Panel B shows the release of inorganic phosphate
from ATP by the GroEL ATPase activity as determined using the Malachite
Green assay. Samples containing the protein(s) are indicated by a  sign in
the table at the bottom of the graph. The addition of YbbN results in a statis-
tically significant (asterisk; p value 0.05 by Student’s t test) decrease in the
GroEL ATPase activity, in agreement with the diminution of chaperone activ-
ity shown in panel A. Bovine serum albumin (BSA) was used as a negative
control. Data are from three independent experiments.
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combined at a 2:1 stoichiometry of YbbN to GroEL monomer.
The kinetics of CS activity recovery was also monitored, and
YbbN inhibited GroESL activity over the entire 120-min dura-
tion of the kinetics experiment (supplemental Fig. 4). At early
time points (up to 40 min), YbbN almost completely inhibited
GroESL-assisted recovery of CS activity. As an independent
measure of GroESL activity, we measured the ATPase activity
that plays an important role in regulating conformational
changes in the GroESL complex, which facilitates folding and
release of substrate protein. Consistent with mild inhibition of
GroEL chaperone activity, YbbN also decreases the release of
inorganic phosphate release from GroEL-bound ATP as mon-
itored using Malachite Green (Fig. 7B). We note that YbbN
alone shows a measureable ATPase activity in this assay,
although the relevance of this weak activity is unclear.
YbbNmay interact with GroEL either as a substrate or, alter-
natively, as a negative regulator. Although the details of YbbN-
GroEL binding are still unclear, the data suggest that YbbN is a
negative regulator of GroEL activity in vitro. If YbbN were a
GroESL substrate, it could lead to the observed decrease in CS
activity recovery by competing with CS for GroESL binding.
However, if thismodel were correct, theGroELATPase activity
that is coupled to client protein folding and releasewould either
be unaffected or enhanced by YbbN binding as a substrate,
which is not observed. In addition, YbbN does not display the
characteristics of a poorly folded protein during purification,
forms well diffracting crystals, and does not have a significant
amount of solvent-exposed hydrophobic surface area in this
structure. All of these observations inveigh against the hypoth-
esis that YbbN is a transiently unfolded client of GroESL and
suggest that it interacts with GroEL in a regulatory fashion.
DISCUSSION
Multidomain proteins containing a Trx-like domain are
widespread; however, only a few have been structurally charac-
terized in their full-length forms (38). YbbN is the first crystal
structure of a Trx-TPR domain fusion protein to be reported in
the literature and reveals that the Trx domain is likely catalyti-
cally inactive andmakes few direct contacts with the rest of the
protein. Although the classical Trx active site is not preserved
in YbbN, the Trx domain does contain two cysteine residues,
and early reports suggested that YbbN possesses a weak oxi-
doreductase activity (10). Therefore, it is possible that this
domain may retain some redox role, possibly similar to other
1-Cys variants of the Trx-fold that have glutaredoxin activities
(39). However, we note that the CXXC motif in YbbN homo-
logues is poorly conserved at both cysteine positions (supple-
mental Fig. 1), and several close YbbNhomologues from genera
Actinobacillus, Haemophilus, and Vibrio with50% sequence
identity to YbbN lack both active site cysteine residues. This
observation requires either that some of YbbN homologues are
redox active, whereas others are not, or that the entire group of
YbbN homologues are not functional oxidoreductases. The
later hypothesis is more consistent with recent biochemical
data (8).
Because it lacks a classical oxidoreductase activity, the func-
tion of the Trx domain in YbbN is unclear. We and others (8)
failed to identify any common Trx-interacting proteins in pull-
down experiments with YbbN, suggesting that the Trx domain
does not function as a specific “bait” domain to facilitate inter-
actions betweenYbbNand classical Trx binding proteins. Some
Trx-fold proteins, such as the peroxiredoxins, can form large
annular oligomers in stress conditions and activate a latent
chaperone activity (40), and it has been proposed that the Trx-
fold may have been the template for an ancient proto-chaper-
onin (41). Although this would provide an appealing explana-
tion for the role of the Trx domain in YbbN and is consistent
with some previous work (10), we found using sedimentation
equilibrium centrifugation that YbbN is amonomer is solution,
and we could detect no chaperone activity for YbbN using a
standard foldase assay. Instead of favoring oligomerization, the
crystal structure of YbbN suggests that the N-terminal Trx
domain might prevent the association of the C-terminal TPR
motifs into larger assemblies, which is a commonmode of self-
interaction for TPRmotifs (33, 36).We therefore speculate that
the Trx domain in YbbN may serve a purpose that is similar to
that of synthetic Trx domain fusions used in recombinant
protein expression; it facilitates the formation of soluble, well
folded, monomeric YbbN protein and prevents unwanted
aggregation. This hypothesis is amenable to direct testing both
in vitro and in vivo.
Protein interaction studies by multiple groups (8, 11) have
shown that YbbN interacts with GroEL, which we corroborate
in this work. In this study YbbN bound GroEL more strongly
than any other detected protein in E. coli lysate, as judged by its
elution behavior from a YbbN affinity resin. Poorly folded pro-
teins often bind to GroEL tenaciously during overexpression
and purification (42), and we cannot rule out that YbbN sam-
ples a partially unstructured conformation that binds to GroEL
in this experiment. However, His6-tagged YbbN did not co-pu-
rify with large amounts of GroEL during purification, contrary
to the expected copurification of the two proteins if YbbNwere
partially unstructured and strongly binding to GroEL as a sub-
strate, suggesting that YbbN does not act as a substrate for
GroEL under these conditions. It would be interesting to know
how these two proteins interact and how this interaction mod-
ulates GroEL activity. Although the binding interface between
YbbN and GroEL is not yet known, TPR domains are protein
interactionmotifs that are known to bind to chaperones (37, 43,
44), and thus we propose that the C-terminal TPR domain of
YbbN is likely involved in this interaction.
We found that YbbN mildly inhibits GroESL chaperone
function in refolding chemically denatured CS and also inhibits
GroESL ATPase activity. The inhibitory effect of YbbN on
GroESL was surprising and suggests a potential role for YbbN
in regulating GroESL function. Previous work has shown that
YbbN enhances the chaperone activity of theDnaK-DnaJ-GrpE
complex (8), an alternative prokaryotic chaperone that is
homologous to eukaryotic Hsp70. DnaK-DnaJ-GrpE is not
functionally redundant with GroESL, and these chaperones
have distinct substrate preferences (45). As YbbN appears to be
a positive regulator of DnaK-DnaJ-GrpE (8) and a negative reg-
ulator of GroESL, we propose the hypothesis that YbbN may
function tomanage client protein traffic to prokaryotic chaper-
ones by actively favoring the DnaK-DnaJ-GrpE system. This
would serve to direct badly misfolded proteins to the DnaK
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system first, whichwill then either directly refold these proteins
or pass a partially folded intermediate to theGroESL system for
completion of renaturation. This is advantageous because ini-
tial binding of extensively unfolded proteins to GroESL may
result in many futile cycles of substrate binding, abortive
incomplete folding, and rebinding of the still-damaged protein
toGroESL. The initial action of theDnaK-DnaJ-GrpE system in
directing partially folded intermediates to downstream chaper-
onins is consistent with current models of the integration of
chaperone networks in E. coli (46), making such an activity for
YbbN plausible. To the best of our knowledge YbbN would be
the first protein identified as a coordinate regulator of the
GroESL and DnaK chaperone systems, although this hypothe-
sis is still speculative and requires additional testing.
There are other proteins in addition to YbbN that contain
both a Trx domain and TPR motifs. The best studied of these
proteins is Arabidopsis thaliana TDX, which contains an
N-terminal set of three TPR motifs and a C-terminal Trx
domain (47), a reversed domain order compared with YbbN.
A. thaliana TDX is both a chaperone and an oxidoreductase
and can protect Arabidopsis against heat stress when overex-
pressed. Unlike YbbN, A. thaliana TDX contains a classic
CXXCTrx active site (48) and forms higher oligomers that con-
vert the protein from a foldase to a holdase chaperone (47).
Although the three-dimensional structure of A. thaliana TDX
is not known, it has been proposed that the TPR domain binds
to andmasks the active site of theTrx domain, implying a direct
interaction between these domains (47). This is in sharp con-
trast to YbbN, which lacks robust oxidoreductase activity, has
no contacts between the TPR and Trx domains in the crystal
structure, and does not possess a foldase chaperone activity.
Therefore, even within the single class of Trx-TPR domain
fusions, there is substantial functional diversity among the con-
stituent members.
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Supplemental Figure 1:  Sequence alignment of YbbN homologues 
!
!
Sequence alignments performed in ClustalW for a selection of YbbN homologues, showing that 
the CxxC motif in the Trx domain (red box) is poorly conserved.  The degree of conservation at 
each position is shown below the alignment in gray bars, with increased height indicating higher 
conservation.  Below that, the secondary structure for E. coli YbbN determined from the crystal 
structure is represented with cylinders indicating helices and arrows indicating strands. A 
number of proteins lack both active site cysteine residues, implying either functional distinctions 
exist between them or that YbbN homologues are not oxidoreductases. 
Supplemental Figure 2:  A calcium binding site at the C-terminus of YbbN 
 
!
 
The C-terminus of one YbbN molecule (black carbons) creates a Ca2+ biding site with a 
neighboring molecule in the lattice (grey carbons).  2mFo-DFc electron density contoured at 1.0 ! 
is shown in blue and residues that contribute a coordinating atom to Ca2+ (yellow) are labeled.  
Primes indicate a residue contributed from the neighboring molecule in the crystal.  The Ca2+ is 
bound in a heptacoordinate, distorted octahedral fashion.  Although this bound calcium is likely 
an artifact of crystallization, the corresponding region of related protein structures 3QDN and 
2R5S also bind to buffer components. 
Supplemental Figure 3:  Resin-immobilized YbbN binds GroEL tightly  
 
 
 
A Coomassie blue-stained SDS-PAGE gel of proteins eluted from a YbbN affinity resin by 
denaturation with SDS.  YbbN was immobilized on cyanogen bromide-activated resin and used 
to reverse purify interacting proteins from clarified E. coli lysate as described in Experimental 
Procedures.  After the final 1.0 M NaCl elution, a portion of the resin was heated to 95°C in 
SDS-containing loading buffer and the supernatant analyzed by SDS-PAGE.  Two strong bands 
appear: one matching the molecular weight of GroEL and the other matching the migration of 
YbbN.   Although YbbN is initially covalently attached to cyanogen bromide-activated resin via 
moderately stable isourea linkages, heating in SDS loading buffer disrupts some of these bonds, 
releasing a portion of the bound YbbN into the soluble fraction.
Supplemental Figure 4:  YbbN suppresses refolding of citrate synthase by the GroESL 
chaperonin system. 
 
 
 
Kinetics of citrate synthase (CS) refolding.  The recovery of CS activity was measured as a 
function of time after dilution of denatured CS into refolding buffer alone (filled circles) or 
containing the protein(s) indicated in the inset, as described in the Experimental Procedures.  
GroELS significantly improves the recovery of CS activity (open circles), consistent with its role 
as a chaperonin. The presence of YbbN at a 2:1 molar ratio with GroEL partially inhibits CS 
renaturation (filled triangles) over the entire 120 minute duration of the experiment.  Notably, 
YbbN almost completely inhibits GroESL chaperone activity at early timepoints in this 
experiment (up to about 40 minutes).  The data are fit with exponential models (solid lines). 
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